FDA NDC Directory · JSON-LD · Markdown

Eohilia

NDC 64764-105 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameBudesonide
Labeler / ManufacturerTAKEDA PHARMACEUTICALS AMERICA, INC.
Marketing categoryNew Drug Application (innovator) · App NDA213976
Dosage form / routeSUSPENSION · ORAL
Active ingredientsBUDESONIDE (2 mg/10mL)
Marketing started20240209
Package count2

External sources

Source: openFDA. Public-domain (CC0).